EYPT
EYPT
NASDAQ · Pharmaceuticals

Eyepoint Inc

$0.35
-0.03 (-8.32%)
As of Nov 7, 1:53 AM ET ·
Analyst Consensus
Buy
19
Analysts
High
Coverage
Buy 12 63%
Hold 7 37%
Sell 0 0%
Price Target
Analyst Price Target +2,543.5% upside
Low Target $6.71
Average Target $9.21
High Target $14.14
Current Price $0.35
Current
$0.35
Target
$9.21
$6.71 $9.21 avg $14.14
Scenario Analysis
Bear Case
$6.71
1,825.9%
Low target
Base Case
$9.21
+2,543.5%
Avg target
Bull Case
$14.14
+3,958.6%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$19.11
-98.2% from high
52-Week Low
$0.34
+1.1% from low
Target vs 52W High
$9.21
-51.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%